Related references
Note: Only part of the references are listed.Aged care staff perceptions of an online training program for responsive behaviours of residents with dementia
Hend Almutairi et al.
AUSTRALASIAN JOURNAL ON AGEING (2022)
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease 2019
Emma Nichols et al.
LANCET PUBLIC HEALTH (2022)
Pattern of prescription of psychotropics (antipsychotics, antidepressants and benzodiazepines) in Western Australian residential aged care facilities
Hend Almutairi et al.
INTERNAL MEDICINE JOURNAL (2021)
The Negative Impact of Psychotropic Drug Use on Quality of Life in Nursing Home Patients at Different Stages of Dementia: Cross-Sectional Analyses from the COSMOS Trial
Erika Ito et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2020)
Optimisation of medications used in residential aged care facilities: a systematic review and meta-analysis of randomised controlled trials
Hend Almutairi et al.
BMC GERIATRICS (2020)
Drug related problems in older adults living with dementia
Sirasa Ruangritchankul et al.
PLOS ONE (2020)
The extent of antipsychotic use in Australian residential aged care facilities and interventions shown to be effective in reducing antipsychotic use: A literature review
Kerrie Westaway et al.
DEMENTIA-INTERNATIONAL JOURNAL OF SOCIAL RESEARCH AND PRACTICE (2020)
More action needed: Psychotropic prescribing in Australian residential aged care
Juanita Westbury et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2019)
The association between specific neuropsychiatric disturbances in people with Alzheimer's disease and dementia with Lewy bodies and carer distress
Toril Marie Terum et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2019)
Neuropsychiatric Symptoms in Dementia: Considerations for Pharmacotherapy in the USA
Stephanie V. Phan et al.
DRUGS IN R&D (2019)
Why deprescribing antipsychotics in older people with dementia in long-term care is not always successful: Insights from the HALT study
Liesbeth Aerts et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2019)
Management of Behavioral and Psychological Symptoms of Dementia
Laurel J. Bessey et al.
CURRENT PSYCHIATRY REPORTS (2019)
Pharmacologic Management of Agitation in Patients with Dementia
Cara L. McDermott et al.
CURRENT GERIATRICS REPORTS (2019)
Alzheimer disease: Non-pharmacological and pharmacological management of cognition and neuropsychiatric symptoms
Samantha M. Loi et al.
AUSTRALASIAN PSYCHIATRY (2018)
The impact of nurse and care staff education on the functional ability and quality of life of people living with dementia in aged care: A systematic review
Michael Bauer et al.
NURSE EDUCATION TODAY (2018)
Impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people with dementia living in nursing homes: A cluster-randomised controlled trial
Clive Ballard et al.
PLOS MEDICINE (2018)
Psychotropic medications in older people in residential care facilities and associations with quality of life: a cross-sectional study
Stephanie L. Harrison et al.
BMC GERIATRICS (2018)
Medication review plus person-centred care: a feasibility study of a pharmacy-health psychology dual intervention to improve care for people living with dementia
Ian D. Maidment et al.
BMC PSYCHIATRY (2018)
Psychotropic drug prescription for nursing home residents with dementia: prevalence and associations with non-resident-related factors
Claudia H. W. Smeets et al.
AGING & MENTAL HEALTH (2018)
Evidence-Based Nonpharmacological Practices to Address Behavioral and Psychological Symptoms of Dementia
Kezia Scales et al.
GERONTOLOGIST (2018)
Impact of antipsychotic review and non-pharmacological intervention on health-related quality of life in people with dementia living in care homes: WHELDa factorial cluster randomised controlled trial
Clive Ballard et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2017)
Neuropsychiatric symptoms in Alzheimer's disease: associations with caregiver burden and treatment outcomes
C. T. Chen et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2017)
Reliability, validity and clinical correlates of the Quality of Life in Alzheimer's disease (QoL-AD) scale in medical inpatients
Gustav Torisson et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2016)
Dose Equivalents for Antipsychotic Drugs: The DDD Method
Stefan Leucht et al.
SCHIZOPHRENIA BULLETIN (2016)
Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials
Yu Hayasaka et al.
JOURNAL OF AFFECTIVE DISORDERS (2015)
A 12-month follow-up study of RedUSe: a trial aimed at reducing antipsychotic and benzodiazepine use in nursing homes
Juanita Westbury et al.
INTERNATIONAL PSYCHOGERIATRICS (2011)
Determinants of Quality of Life in Nursing Home Residents with Dementia
R. B. Wetzels et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2010)
G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences
Franz Faul et al.
BEHAVIOR RESEARCH METHODS (2007)
Whose quality of life is it anyway? The validity and reliability of the quality of life-Alzheimers disease (QoL-AD) scale
L Thorgrimsen et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2003)
Share Paper
